Japan approves AstraZeneca’s Calquence for adult patients with treatment-naïve CLL
Calquence was previously approved in Japan for the treatment of adults with relapsed or refractory Chronic Lymphocytic Leukaemia…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Japan
KM Biologics commences clinical trial of COVID-19 vaccine candidate
The study is a combined Phase 1 and Phase 2 trial involving 210 subjects to test the vaccine’s safety and ability to trigger an…
QUAD pledges to supply billion doses of COVID-19 vaccine across Asia by 2022
The leaders also agreed to set up an experts’ group to help distribute vaccines, as well as working groups on climate change,…
Quad nations meet to declare financing to enhance India vaccine output – US official
The aim of the initiative by the Quad, which groups the US, India, Japan and Australia, would be to reduce manufacturing backlogs,…
Sai Life Sciences opens representative office in Tokyo, Japan
It has over 2000 employees across its facilities in India, UK and US
Gilead gets approval for Jyseleca (filgotinib) in Japan for rheumatoid arthritis
Gilead Japan will hold marketing authorisation of Jyseleca in Japan while Eisai will be responsible for product distribution
Sun Pharma launches ILUMYA (tildrakizumab) in Japan
It is indicated for the treatment of plaque psoriasis in adult patients who have an inadequate response to conventional therapies…
Pharma Secretary urges closer cooperation between India, Japan in pharma, med devices sector
He was addressing a virtual investment forum for Japanese investors
J&J in talks with Japan, Gates Foundation to lock in deals on COVID-19 vaccine
J&J has already agreed to prioritize an allocation to the United States as part of its funding agreement with the U.S.…
Psoriasis digital landscape for patients in Japan offers competent patient engagement: says…
According to GlobalData’s Epidemiology and Market Size Database, the value of the plaque psoriasis market in Japan is estimated to…